Sars Cov2 Antikörper Test Mit Sehr Hoher Spezifität

Human anti-SARS-CoV2(N) IgG ELISA Kit

EKF60809-48T 48T
EUR 400.4

Human IgG antibody Laboratories manufactures the sars cov2 antikörper test mit sehr hoher spezifität reagents distributed by Genprice. The Sars Cov2 Antikörper Test Mit Sehr Hoher Spezifität reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Cov2 Group: Antikörper Test

Human anti-SARS-CoV2(S) IgG ELISA Kit

96T
EUR 572

CoV2 Nucleocapsid

100µg
EUR 275
Description: Polyclonal Rabbit Anti Full Length CoV2 Nucleocapsid

CoV2 Paired

50µg
EUR 165
Description: Mouse Anti SARS CoV-2 Paired

Human IgG Quick test strip

10 tests
EUR 150

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

100 µl
EUR 650

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

1 ml
EUR 7200

Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit

200 µl
EUR 2100

Antikörper Test information

SARS-Cov2-NP2-Antibody

E10-31942P N/A
EUR 276.5
Description: N/A

SARS-Cov2-NP2-Antibody

E10-31943P N/A
EUR 276.5
Description: N/A

SARS-Cov2-NP1-Antibody

E10-31963P N/A
EUR 276.5
Description: N/A

SARS-Cov2-NP1-Antibody

E10-31964P N/A
EUR 276.5
Description: N/A

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 1T
EUR 9.6
  • when the Ct value ≤ 37 the sensitivity was 94.483% (95%CI: 89.418%, 97.588%) and specificity was 99.327% (95%CI: 97.589%, 99.918%). when the Ct value ≤ 30 the sensitivity was 96.330% (95%CI: 90.870%, 98.991%) and specificity was 99.327% (95%CI: 9
  • Show more
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 25T/kit
EUR 42
  • Relative sensitivity: 96.17 %
  • Relative specificity: >99.9%
  • Accuracy:98.79%%
  • Specimen: Saliva, 10-20 minutes to get results
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-100g 100 µg
EUR 850

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-20g 20 µg
EUR 100

SARS-CoV-2 Antigen Rapid Test Kit

abx294181-50g 50 µg
EUR 450

SARS-CoV-2 Antigen Rapid Test Kit

GF101A2 25 Test/kit Ask for price

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G 25 Tests/Kit
EUR 112.8
  • Test type: Qualitative
  • Sample type: Nasal swab
  • Target antigen: Nucleocapsid (N)
  • Time to result: 15 minutes (Readout window 15 - 30 minutes)
  • Stability (test, opened pouch): 1 hour once the test has been opened
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-100l 100 µl
EUR 650

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-1ml 1 ml
EUR 10500

SARS-CoV-2-Spike Antibody Rapid Test Kit

abx090710-200l 200 µl
EUR 2100

SARS-CoV2 FL Spike Protein

0573-001 100 ug
EUR 395
  • ELISA, WB

SARS-Cov2-Neutralizing-Antibody(Spike)

E28F03095-100ug N/A
EUR 444.44
Description: N/A

SARS-Cov2-Neutralizing-Antibody(Spike)

E28F03095-1mg N/A
EUR 1777.78
Description: N/A